Lumican, a small leucine-rich proteoglycan substituted with keratan sulfate chains is expressed and secreted by human melanoma cells and not normal melanocytes

IUBMB Life

Volumn 58, Issue 10, 2006, Pages 606-610

  Sifaki, M ^b   Assouti, M ^a   Nikitovic, D ^a   Krasagakis, K ^b   Karamanos, N K ^c   Tzanakakis, George N ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^c UNIVERSITY OF PATRAS   (Greece)

Author keywords

Glycoproteins; Human cells; Keratan sulphate; Melanoma; Proteoglycans

Indexed keywords

KERATAN SULFATE; LEUCINE; LUMICAN; MESSENGER RNA; PROTEIN ANTIBODY; PROTEOGLYCAN;

ARTICLE; CANCER GROWTH; CELL JUNCTION; CONTROLLED STUDY; DERMIS; ENZYME SPECIFICITY; EPIDERMIS; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN CELL; MELANOCYTE; MELANOMA; MELANOMA CELL; METASTASIS; MICROENVIRONMENT; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

CELL LINE, TUMOR; CELLS, CULTURED; CHONDROITIN SULFATE PROTEOGLYCANS; HUMANS; KERATAN SULFATE; MELANOCYTES; MELANOMA; PROTEOCHONDROITIN SULFATES; RNA, MESSENGER;

EID: 33749528370     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1080/15216540600951605     Document Type: Article

References (21)

1. Houghton, A. N., and Polsky, D. (2002) Focus on melanoma. Cancer Cell 2, 275-278.
2. Lever, W. F. (2005) Histopathology of the Skin, Lippincott, Williams and Wilkins, Philadelphia, USA.
3. Selvamurugan, N., Fung, Z., and Partridge, N. C. (2002) Transcriptional activation of collagenase-3 by transforming growth factor-β1 is via MAPK and SMAD pathways in human breast cancer cells. FEBS Lett. 532, 31-35.
4. Hakamori, S., and Handa, K. (2002) Glycosphingolipid-dependent cross-talk between glycosynapses interfacing tumor cells with their host cells: essential basis to define tumor malignancy. FEBS Lett. 531, 88-92.
5. Nikitovic, D., Zafiropoulos, A., Katonis, P., Tsatsakis, A., Theocharis, A. D., Karamanos, N. K., and Tzanakakis, G. N. (2006) Transforming growth factor-beta as a key molecule triggering the expression of versican isoforms v0 and v1, hyaluronan synthase-2 and synthesis of hyaluronan in malignant osteosarcoma cells. IUBMB Life 58, 47-53.
6. Wang, Y. N., and Sanders, J. E. (2003) How does skin adapt to repetitive mechanical stress to become load tolerant? Med. Hypotheses 61, 29-35.
7. Carrino, D. A., Sorrell, J. M., and Caplan, A. I. (2000) Age-related changes in the proteoglycans of human skin. Arch. Biochem. Biophys. 373, 91-101.
8. Vuillermoz, B., Wegrowski, Y., Contet-Audonneau, J. L., Danoux, L., Pauly, G., and Maquart, F. X. (2005) Influence of aging on glycosaminoglycans and small leucine-rich proteoglycans production by skin fibroblasts. Mol. Cell. Biochem. 277, 63-72.
9. Naito, Z. (2005) The role of small leucine-rich proteoglycan (SLRP) family in pathological lesions and cancer cell growth. J. Nippon Med. Sch. 72, 137-145.
10. Lu, Y. P., Ishiwata, T., Kawahara, K., Watanabe, M., Naito, Z., Moriyama, Y., Sugisaki, Y., and Asano, G. (2002) Expression of lumican in human colorectal cancer cells. Pathol. Int. 52, 519-526.
11. Naito, Z., Ishiwata, T., Kurban, G., Teduka, K., Kawamoto, Y., Kawahara, K., and Sugisaki, Y. (2002) Expression and accumulation of lumican protein in uterine cervical cancer cells at the periphery of cancer nests. Int. J. Onc. 20, 943-948.
12. Lu, Y. P., Ishiwata, T., and Asano, G. (2002) Lumican expression in alpha cells of islets in pancreas and pancreatic cancer cells. J. Pathol. 196, 324-330.
13. Leygue, E., Snell, L., Dotzlaw, H., Hole, K., Hiller-Hitchcock, T., Roughley, P. J., Watson, P. H., and Murphy, L. C. (1998) Expression of lumican in human breast carcinoma. Cancer Res. 58, 1348-1352.
14. Troup, S., Njue, C., Kliewer, E. V., Parisien, M., Roskelley, C., Chakravarti, S., Roughley, P. J., Murphy, L. C., and Watson, P. H. (2003) Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer. Clin. Cancer Res. 9, 207-214.
15. Koninger, J., Giese, T., di Mola, F. F., Wente, M. N., Esposito, I., Bachem, M. G., Giese, N. A., Buchler, M. W., and Friess, H. (2004) Pancreatic tumor cells in.uence the composition of the extracellular matrix. Biochem. Biophys. Res. Commun. 322, 943-949.
16. Vuillermoz, B., Khoruzhenko, A., D'Onofrio, M. F., Ramont, L., Venteo, L., Perreau, C., Antonicelli, F., Maquart, F. X., and Wegrowski, Y. (2004) The small leucine-rich proteoglycan lumican inhibits melanoma progression. Exp. Cell. Res. 296, 294-306.
17. Kusafuka, K., Ishiwata, T., Sugisaki, Y., Takemura, T., Kufasuka, M., Hisha, H., and Ikehara, S. (2004) Lumican expression is associated with the formation of mesenhyme-like elements in salivary pleomorphic adenomas. J. Pathol. 203, 953-960.
18. Cornuet, P. K., Blochberger, T. C., and Hassell, J. R. (1994) Molecular polymorphism of lumican during corneal development. Invest. Ophthalmol. Vis. Sci. 35, 870-877.
19. Grover, J., Chen, X. N., Korenberg, J. R., and Roughley, P. J. (1995) The human lumican gene. J. Biol. Chem. 270, 21942-21949.
20. Funderburgh, J.L., Mitschler, R. R., Funderburgh, M. L., Roth, M.R., Chapes, S. K., and Conrad, G. W. (1997) Macrophage receptors for lumican. A corneal keratan sulfate proteoglycan. Invest. Ophthalmol. Vis. Sci. 38, 1159-1167.
21. Hockel, M., and Vaupel, P. (2001) Biological consequences of tumor hypoxia. Semin. Oncol. 28, 36-41.